Cart
sales@molnova.com
Compound 3A
CAS No. 1822358-25-7
Compound 3A( —— )
Catalog No. M19944 CAS No. 1822358-25-7
Compound 3A can effectively inhibit the transcription of RNA polymerase I in the A375 malignant melanoma cell line but has no effect on polymerase II.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 87 | In Stock |
|
| 10MG | 132 | In Stock |
|
| 25MG | 205 | In Stock |
|
| 50MG | 309 | In Stock |
|
| 100MG | 447 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCompound 3A
-
NoteResearch use only, not for human use.
-
Brief DescriptionCompound 3A can effectively inhibit the transcription of RNA polymerase I in the A375 malignant melanoma cell line but has no effect on polymerase II.
-
DescriptionCompound 3A can effectively inhibit the transcription of RNA polymerase I in the A375 malignant melanoma cell line but has no effect on polymerase II.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorRNA polymerase I
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1822358-25-7
-
Formula Weight356.42
-
Molecular FormulaC21H20N6
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@H]1CN(C[C@@H](C)N1)c1ccc2cc(C#N)c3nc4ccccc4n3c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen L L Song J X Lu J H et al. Corynoxine a Natural Autophagy Enhancer Promotes the Clearance of Alpha-Synuclein via Akt/mTOR Pathway[J]. Journal of Neuroimmune Pharmacology 2014 9(3):380-387.
molnova catalog
related products
-
SR15006
SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).
-
DY-46-2
DY-46-2 is a selective non-nucleoside DNA methyltransferase 3A (DNMT3A) inhibitor (IC50: 0.39 ± 0.23 μM) with anticancer activity for the study of cancer and tumors.
-
1,4-Dideoxy-1,4-epit...
1,4-Dideoxy-1,4-epithio-D-ribitol is a purine nucleoside analog that targets malignant tumors of the inert lymphatic system and possesses a broad spectrum of antitumor activity.1,4-Dideoxy-1,4-epithio-D-ribitol induces apoptosis through inhibition of DNA synthesis.
